Why Delcath Systems Shares Are Trading Higher By Around 58%; Here Are 20 Stocks Moving Premarket

Gainers

  • Delcath Systems, Inc. DCTH shares surged 57.7% to $4.93 in pre-market trading after the company reported the FDA approval of HEPZATO KIT™ for the treatment of adult patients with unresectable hepatic-dominant metastatic uveal melanoma.
  • Sonim Technologies, Inc. SONM rose 29.1% to $0.71 in pre-market trading after the company reported a 125% revenue increase in the second quarter.
  • G Medical Innovations Holdings Ltd GMVD shares gained 21% to $0.2299 in pre-market trading after falling over 7% on Monday.
  • T2 Biosystems, Inc. TTOO shares gained 18.4% to $0.4619 in pre-market trading after jumping 15% on Monday.
  • The Arena Group Holdings, Inc. AREN shares climbed 18.3% to $4.00 in pre-market trading after the company announced it signed a binding letter of intent to combine with Bridge Media Networks.
  • LL Flooring Holdings, Inc. LL shares rose 12.5% to $4.22 in pre-market trading after the company’s board announced exploration of strategic alternatives, including a sale.
  • Castellum, Inc. CTM rose 10.8% to $0.5320 in pre-market trading after posting better-than-expected quarterly sales.
  • Siyata Mobile Inc. SYTA shares rose 10.8% to $3.68 in pre-market trading following upbeat quarterly sales.
  • Grove Collaborative Holdings, Inc. GROV gained 10.5% to $2.42 in pre-market trading after the company posted strong quarterly sales and announced leadership changes.
  • Taysha Gene Therapies, Inc. TSHA gained 9.4% to $2.33 in pre-market trading. Taysha Gene Therapies shares jumped 188% on Monday after the company reported initial clinical data from the first adult Rett Syndrome patient dosed in the REVEAL Phase 1/2 trial and announced $150 million private placement financing.

Losers

  • F45 Training Holdings Inc. FXLV fell 62.7% to $0.2695 in pre-market trading after the company announced its intent to voluntarily delist and deregister its securities.
  • Altisource Asset Management Corporation AAMC shares fell 61.3% to $12.72 in pre-market trading after the company posted a wider second-quarter loss.
  • Alaunos Therapeutics, Inc. TCRT shares fell 49.4% to $0.1993 in pre-market trading after posting a loss for the second quarter.
  • Design Therapeutics, Inc. DSGN fell 37.9% to $4.55 in pre-market trading after the company reported second-quarter results and announced initial results from Phase 1 multiple-ascending dose study of DT-216 for the treatment of Friedrich Ataxia.
  • MGO Global, Inc. MGOL fell 32.3% to $1.53 in pre-market trading.
  • OptimizeRx Corporation OPRX shares fell 22.4% to $9.75 in pre-market trading after posting weak quarterly sales.
  • TFF Pharmaceuticals, Inc. TFFP fell 22.2% to $0.35 in pre-market trading after the company reported second-quarter results and priced $5 million public offering of common stock.
  • Aptevo Therapeutics Inc. APVO fell 21.1% to $0.3554 in pre-market trading. Aptevo Therapeutics recently posted a wider-than-expected quarterly loss.
  • Jet.AI Inc. JTAI fell 18.8% to $4.06 in pre-market after declining 25% on Monday.
  • Getty Images Holdings, Inc. GETY fell 18.6% to $3.70 in pre-market trading after the company reported second-quarter earnings.

Now Read This: Home Depot, Agilent Technologies And 3 Stocks To Watch Heading Into Tuesday

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsPenny StocksSmall CapPre-Market OutlookMarketsMoversTrading IdeasConsumer DiscretionaryHome Improvement RetailPremarket MoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!